These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 16614105)
1. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Bray F; Richiardi L; Ekbom A; Forman D; Pukkala E; Cuninkova M; Møller H Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):652-8. PubMed ID: 16614105 [TBL] [Abstract][Full Text] [Related]
2. Testicular cancer incidence in eight northern European countries: secular and recent trends. Richiardi L; Bellocco R; Adami HO; Torrång A; Barlow L; Hakulinen T; Rahu M; Stengrevics A; Storm H; Tretli S; Kurtinaitis J; Tyczynski JE; Akre O Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2157-66. PubMed ID: 15598775 [TBL] [Abstract][Full Text] [Related]
3. Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996. Weir HK; Marrett LD; Moravan V CMAJ; 1999 Jan; 160(2):201-5. PubMed ID: 9951441 [TBL] [Abstract][Full Text] [Related]
4. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Bray F; Ferlay J; Devesa SS; McGlynn KA; Møller H Nat Clin Pract Urol; 2006 Oct; 3(10):532-43. PubMed ID: 17031378 [TBL] [Abstract][Full Text] [Related]
5. Trends in testicular germ cell cancer incidence in Australia. Baade P; Carrière P; Fritschi L Cancer Causes Control; 2008 Dec; 19(10):1043-9. PubMed ID: 18478339 [TBL] [Abstract][Full Text] [Related]
6. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Jacobsen R; Møller H; Thoresen SØ; Pukkala E; Kjaer SK; Johansen C Int J Androl; 2006 Feb; 29(1):199-204. PubMed ID: 16371112 [TBL] [Abstract][Full Text] [Related]
7. Subtype-specific incidence of testicular cancer in Germany: a pooled analysis of nine population-based cancer registries. Stang A; Rusner C; Eisinger B; Stegmaier C; Kaatsch P Int J Androl; 2009 Aug; 32(4):306-16. PubMed ID: 18179558 [TBL] [Abstract][Full Text] [Related]
8. Doubling of testicular cancer incidence rate over the last 20 years in southern France. Walschaerts M; Huyghe E; Muller A; Bachaud JM; Bujan L; Thonneau P Cancer Causes Control; 2008 Mar; 19(2):155-61. PubMed ID: 18236173 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma? Aschim EL; Haugen TB; Tretli S; Daltveit AK; Grotmol T Int J Androl; 2006 Aug; 29(4):458-67. PubMed ID: 16487404 [TBL] [Abstract][Full Text] [Related]
10. Population based incidence and age distribution of spermatocytic seminoma. Carrière P; Baade P; Fritschi L J Urol; 2007 Jul; 178(1):125-8. PubMed ID: 17499277 [TBL] [Abstract][Full Text] [Related]
11. Etiologic differences between seminoma and nonseminoma of the testis: a systematic review of epidemiologic studies. Stang A; Kuss O Hematol Oncol Clin North Am; 2011 Jun; 25(3):473-86, vii. PubMed ID: 21570603 [TBL] [Abstract][Full Text] [Related]
12. [The epidemiology of tumors of the testes in the Netherlands: accurate rendering by the Registry of Histopathology and Cytopathology (PALGA)]. Post PN; Casparie MK; ten Kate FJ; Oosterhuis JW Ned Tijdschr Geneeskd; 2004 Jun; 148(23):1150-4. PubMed ID: 15211966 [TBL] [Abstract][Full Text] [Related]
13. Trends in the incidence of testicular germ cell tumors in the United States. McGlynn KA; Devesa SS; Sigurdson AJ; Brown LM; Tsao L; Tarone RE Cancer; 2003 Jan; 97(1):63-70. PubMed ID: 12491506 [TBL] [Abstract][Full Text] [Related]
14. Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing. Ruf CG; Isbarn H; Wagner W; Fisch M; Matthies C; Dieckmann KP Urol Oncol; 2014 Jan; 32(1):33.e1-6. PubMed ID: 23395239 [TBL] [Abstract][Full Text] [Related]
15. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349 [TBL] [Abstract][Full Text] [Related]
16. Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant. Speaks C; McGlynn KA; Cook MB Cancer Causes Control; 2012 Oct; 23(10):1593-8. PubMed ID: 22941667 [TBL] [Abstract][Full Text] [Related]
17. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases. Dieckmann KP; Albers P; Classen J; De Wit M; Pichlmeier U; Rick O; Müllerleile U; Kuczyk M J Urol; 2005 Mar; 173(3):824-9. PubMed ID: 15711278 [TBL] [Abstract][Full Text] [Related]
18. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Bray F; Carstensen B; Møller H; Zappa M; Zakelj MP; Lawrence G; Hakama M; Weiderpass E Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2191-9. PubMed ID: 16172231 [TBL] [Abstract][Full Text] [Related]
19. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007. Trabert B; Chen J; Devesa SS; Bray F; McGlynn KA Andrology; 2015 Jan; 3(1):4-12. PubMed ID: 25331326 [TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of 87 cases of testicular tumor]. Zheng LW; Li FB; Liu RZ; Ji RG; Zhao ZW Zhonghua Nan Ke Xue; 2005 Jun; 11(6):445-7. PubMed ID: 15999491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]